ST. LOUIS–(BUSINESS WIRE)–Thompson Street Capital Partners (TSCP), a private equity firm based in St. Louis, today announced the acquisition of the assets of BioST. LOUIS–(BUSINESS WIRE)–Thompson Street Capital Partners (TSCP), a private equity firm based in St. Louis, today announced the acquisition of the assets of Bio

Thompson Street Capital Partners Portfolio Company PestCo Holdings Acquires Bio-Tech Pest Control

2026/01/07 19:34
2 min di lettura
Per feedback o dubbi su questo contenuto, contattateci all'indirizzo crypto.news@mexc.com.

ST. LOUIS–(BUSINESS WIRE)–Thompson Street Capital Partners (TSCP), a private equity firm based in St. Louis, today announced the acquisition of the assets of Bio-Tech Pest Control (Bio-Tech) by PestCo Holdings, LLC (PestCo), a growth-oriented, national provider of pest control services to residential and commercial customers and a TSCP portfolio company. Based in Spring, TX, Bio-Tech is a leading provider of residential and commercial pest control services throughout metropolitan Houston. This acquisition represents a strategic addition in the Houston market, one of the largest and fastest growing cities in the United States. Terms of the transaction were not disclosed.

“We continue to expand our presence in the great state of Texas and are excited about the addition of the Bio-Tech team to the PestCo family. Our goals remain consistent in that we will strive to earn the loyalty of each Bio-Tech customer, while expanding opportunities to PestCo team members across the U.S.,” said Jay Keating, CEO of PestCo.

Pierre Riettini and Jason Pitman, owners of Bio-Tech Pest Control, said, “For over 30 years, we worked hard to build a tremendous company with many great people involved along the way. As hard as it is to let go, we felt that PestCo was the right fit, and this is the right time. We know that PestCo will treat our employees and customers every bit as well as we did, and we’re excited to see where Bio-Tech goes from here.”

“Thompson Street is pleased to support PestCo’s continued expansion in the Houston metropolitan area through the acquisition of Bio-Tech, a well-established and respected player in the region,” said Dan Cooper, Managing Director at TSCP.

About Thompson Street Capital Partners

Thompson Street Capital Partners (tscp.com) is a middle-market private equity firm that helps transform already exceptional businesses into market leaders. Based in St. Louis, Missouri, TSCP invests globally in the life sciences and healthcare, software and technology, business and consumer services and products sectors. TSCP partners with management teams to increase value by accelerating growth, both organically and via complementary acquisitions.

Contacts

Camaryn Sapienza

Gregory

(630) 699-9865

csapienza@gregoryagency.com

Opportunità di mercato
Logo BIO Protocol
Valore BIO Protocol (BIO)
$0.01814
$0.01814$0.01814
+4.97%
USD
Grafico dei prezzi in tempo reale di BIO Protocol (BIO)
Disclaimer: gli articoli ripubblicati su questo sito provengono da piattaforme pubbliche e sono forniti esclusivamente a scopo informativo. Non riflettono necessariamente le opinioni di MEXC. Tutti i diritti rimangono agli autori originali. Se ritieni che un contenuto violi i diritti di terze parti, contatta crypto.news@mexc.com per la rimozione. MEXC non fornisce alcuna garanzia in merito all'accuratezza, completezza o tempestività del contenuto e non è responsabile per eventuali azioni intraprese sulla base delle informazioni fornite. Il contenuto non costituisce consulenza finanziaria, legale o professionale di altro tipo, né deve essere considerato una raccomandazione o un'approvazione da parte di MEXC.

$30,000 in PRL + 15,000 USDT

$30,000 in PRL + 15,000 USDT$30,000 in PRL + 15,000 USDT

Deposit & trade PRL to boost your rewards!